LTX-315’s novel mechanism of action directly targets cancerous skin cells to induce an anti-tumor immune response, providing a potential alternative...
Brand Pura H&W™ Brand Pura H&W™The exclusive distribution agreement includes 5 SKUs from Pura H&W’s evidence-based derma-cosmetics portfolio The products...
REHOVOT, Israel, April 05, 2022 (GLOBE NEWSWIRE) -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based...
TORONTO, April 05, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
RESEARCH TRIANGLE PARK, N.C., April 05, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee...
STAMFORD, Conn., April 05, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new...
WINTER SPRINGS, Fla., April 05, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release...
TORONTO, April 05, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical...
Solei’s Balance Cinnamon & Black Currant ‘Solei Bites’ are Now Exclusively Available in Quebec at the SQDC Solei Cannabis ‘Solei...
DEVON, Pa., April 05, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid...
Companies collaborate to design innovative registrational trial of 186RNL for recurrent glioblastoma Proprietary Synthetic Control ArmⓇ solution intended to enhance...
TORONTO and TAMPA, Fla., April 05, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG; TSXV: SLHG) (“Skylight Health” or...
-Multiple tranche debt financing agreement provides Oncorus with access to up to $45 million- -Use of proceeds intended to support...
DURHAM, N.C., April 05, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in...
GENT, Belgium, April 05, 2022 (GLOBE NEWSWIRE) -- eTheRNA immunotherapies NV (“eTheRNA”), an mRNA technology discovery and development company with...
First in human study of drug-enhanced tumor infiltrating lymphocyte therapy in patients with gynecological malignanciesSAN FRANCISCO, April 05, 2022 (GLOBE...
TNX-2300, a Live Virus Vaccine Based on a Bovine Parainfluenza Virus Vector, in Development to Protect Against COVID-19 Co-Expression of...
SEATTLE and CAMBRIDGE, United Kingdom, April 05, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company...
Toronto, Canada--(Newsfile Corp. - April 5, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a...
Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - April 5, 2022) - The Tinley Beverage Company Inc. (CSE:TNY) (OTCQX: TNYBF)...
